Patent US2209478A successfully refreshed from Google Patents.
Patent US5270197A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5270197A Expired / Lapsed US ⏱️ 0.0 years remaining

Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor

Assignee: Boston Children's Hospital
•
Filing: 1990-12-20
•
Granted: 1993-12-14
•
Expires: 2010-12-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A homogeneous population of cells having on average (1) a number of cell surface low-affinity heparin-binding growth factor (HBGF) sites per cell less than 20% of the number of such binding sites found on wild-type CHO-K1 cells (ATCC Accession No. CCL61), and at least three times the number of cell surface high-affinity HBGF receptors per cell found on such CHO-K1 cells; and an assay system utilizing such cells.

Inventors

  • 👤 Avner Yayon
  • 👤 David M. Ornitz
  • 👤 Michael Klagsbrun
  • 👤 Philip Leder

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 20:59
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5008; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/50; C07K14/503; C07K14/705; C07K14/71; C12; C12N; C12N9/00; C12N9/14; C12N9/16; G01N33/74; C07K2319/00; C07K2319/01; C07K2319/034; C07K2319/32; C07K2319/61; G01N2500/00

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 62 words
A homogeneous in vitro population of mammalian cells having on average a number of cell surface low-affinity HBGF-binding sites per cell less than 20% of the number of such binding sites found on wild-type CHO-K1 cells (ATCC Accession No. CCL61), and on average at least three times the number of cell surface high-affinity HBGF receptors per cell found on said CHO-K1 cells.
Claim 2
Dependent Claim 62 words
A homogeneous in vitro population of mammalian cells having on average a number of cell surface low-affinity HBGF-binding sites per cell less than 20% of the number of such binding sites found on wild-type CHO-K1 cells (ATCC Accession No. CCL61), and on average at least three times the number of cell surface high-affinity HBGF receptors per cell found on said CHO-K1 cells.
Claim 3
Dependent Claim 25 words
The population of cells of claim 1 wherein each of the cells in said population comprises a recombinant nucleic acid encoding said high-affinity HBGF receptor.
Claim 4
Dependent Claim 27 words
The population of cells of claim 1, wherein said high-affinity HBGF receptor is endogenous to a species selected from the group consisting of human, mouse, and chicken.
Claim 5
Dependent Claim 18 words
The population of cells of claim 3, wherein said high-affinity HBGF receptor is a mouse high-affinity HBGF receptor.
Claim 6
Dependent Claim 19 words
The population of cells of claim 1, wherein said high-affinity HBGF receptor is a high-affinity aFGF or bFGF receptor.
Claim 7
Dependent Claim 23 words
The population of cells of claim 2, wherein said recombinant nucleic acid is incorporated into the genome of each cell of said population.
Claim 8
Dependent Claim 24 words
The population of cells of claim 2, wherein each cell of said population is transiently transfected with a vector comprising said recombinant nucleic acid.
Claim 9
Dependent Claim 57 words
A system for assaying the ability of a substance to bind to a high-affinity HBGF receptor, which system comprises a cell of the population of cells of claim 1 (the "test cell"), and an amount of heparin or a heparin-like molecule sufficient to induce binding of a HBGF to a high-affinity HBGF receptor on said test cell.
Claim 10
Dependent Claim 43 words
A system for assaying the ability of a substance to affect the interaction between a given type of HBGF and a high-affinity HBGF receptor, which system comprises said given type of HBGF and a cell of the population of cells of claim 1.

References Cited (Backward Citations)

US4882275A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-12-13 1997-06-14 1997-12-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-12-13 2001-06-14 2001-12-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-12-13 2005-06-14 2005-12-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag